Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001396093-08-000007
Filing Date
2008-03-03
Accepted
2008-03-03 14:48:56
Documents
2
Period of Report
2008-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8217
2 powerofattorneykessler.htm EX-24 137
  Complete submission text file 0001396093-08-000007.txt   10440
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 301-770-3099
Kessler Paul D. (Reporting) CIK: 0001428524 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-04829 | Film No.: 08659182